Artesian VC is a venture capital fund specializing in seed-stage investments in health tech and biotech. They support early-stage companies such as Braingaze. Managing $1.22 billion in assets, Artesian has invested in over 600 startups across the Asia Pacific. With offices in Australia, China, Indonesia, Singapore, the US, and the UK, they focus on both venture capital and impact investments. Artesian also provides a Venture Capital as a Service platform to support innovative tech solutions. Follow them on Twitter @artesianvc for updates.
